Evaluation of atezolizumab immunogenicity: Efficacy and safety (Part 2).

Autor: Peters, Solange1 (AUTHOR) Solange.Peters@chuv.ch, Galle, Peter R.2 (AUTHOR), Bernaards, Coen A.3 (AUTHOR), Ballinger, Marcus4 (AUTHOR), Bruno, René5 (AUTHOR), Quarmby, Valerie6 (AUTHOR), Ruppel, Jane6 (AUTHOR), Vilimovskij, Alexandr7 (AUTHOR), Wu, Benjamin8 (AUTHOR), Sternheim, Nitzan9 (AUTHOR), Reck, Martin10 (AUTHOR)
Zdroj: CTS: Clinical & Translational Science. Jan2022, Vol. 15 Issue 1, p141-157. 17p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje